Venture capital funding is drying up, but is this a crisis or an opportunity? Squire Servance, founder of Syridex Bio, explains the βdenominator problem,β why savvy investors are targeting overlooked assets, and how his fund addresses health disparities.
π‘ LINKS TO MORE CONTENT
Subscribe to my newsletter: https://lsg2g.substack.com/
Host: https://www.linkedin.com/in/christiansoschner/
Speaker: https://www.linkedin.com/in/squireservance/